Skip to content

Clinical trials

Cognitive Dysfunction trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Country / region: Greece Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20162
20172
20192
20201
20213
20221
202512
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Unknown status6
Completed4
Not yet recruiting3
Active, not recruiting2
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aristotle University Of Thessaloniki9
Bristol-Myers Squibb2
University College, London2
Altoida1
Attikon Hospital1
Eisai Co., Ltd.1
Elpen Pharmaceutical Co. Inc.1
Greece 2021 Committee1
Greek Alzheimer's Association and Related Disorders1
KAVADIA ELENI1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction27
Alzheimer Disease9
Dementia8
Post-Acute COVID-19 Syndrome2
Stroke2
Vestibular Diseases2
Adjustment Disorders1
Affective Disorders, Psychotic1
Anxiety Disorders1
Asymptomatic Diseases1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.